Cargando…
2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
BACKGROUND: Steroid refractory acute graft- vs. -host-disease (GVHD) after hematopoietic cell transplantation (HCT) is highly morbid with limited treatment options. Murine studies show protection from GVHD with butyrate exposure but direct exposure of stem/progenitor cells to butyrate inhibits colon...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808863/ http://dx.doi.org/10.1093/ofid/ofz359.149 |
_version_ | 1783461840668327936 |
---|---|
author | Golob, Jonathan L DeMeules, Martha M Loeffelholz, Tillie Quinn, Z Z Dame, Michael K Silvestri, Sabrina Wu, Michael Schmidt, Tom Fiedler, Tina L Hoostal, Matthew Mielcarek, Marco Spence, Jason Pergam, Steven A Fredricks, David |
author_facet | Golob, Jonathan L DeMeules, Martha M Loeffelholz, Tillie Quinn, Z Z Dame, Michael K Silvestri, Sabrina Wu, Michael Schmidt, Tom Fiedler, Tina L Hoostal, Matthew Mielcarek, Marco Spence, Jason Pergam, Steven A Fredricks, David |
author_sort | Golob, Jonathan L |
collection | PubMed |
description | BACKGROUND: Steroid refractory acute graft- vs. -host-disease (GVHD) after hematopoietic cell transplantation (HCT) is highly morbid with limited treatment options. Murine studies show protection from GVHD with butyrate exposure but direct exposure of stem/progenitor cells to butyrate inhibits colonic stem cell proliferation. METHODS: Stool samples were collected weekly in a cohort of HCT recipients (n = 210) undergoing allogeneic transplant, and underwent 16S rRNA sequencing to determine the number and relative abundance of butyrogens. Dissociated primary human colonoid cell aggregates (200,000 per well) were plated onto collagen IV-coated transwells (0.4 µm pore size, 0.33 cm(2), PET) in stem cell medium for 24 hours. From 24 hours onwards, the basal-lateral chamber was switched to differentiation medium; the apical chamber was Hanks Buffered Salt Solution (HBSS), HBSS with 10 mM butyrate sodium salt early (24 hours onwards) or late (72hours onwards). Trans-epithelial electrical resistance was measured daily. RESULTS: Retrospective chart review identified 27 recipients who developed acute GVHD of the gut, stratified to be either steroid refractory GVHD (failed to respond to 2 mg/kg of methylprednisolone) or responsive. The presence of butyrogens in the gut microbiome after the onset of severe acute GHVD of the gut associated with increased risk of steroid refractory GVHD (Figure 1; P < 0.05). Direct exposure of human colonic stem/progenitor cells to butyrate inhibits the development of trans-epithelial electrical resistance; exposure after differentiation had no inhibition of barrier formation (Figure 2; P < 0.05 by T-test). CONCLUSION: Butyrogens may help prevent the development of acute GVHD of the gut, but once severe GVHD has developed may inhibit recovery due to the loss of crypt architecture exposing colonic stem cells to microbe-produced butyrate with impaired differentiation and cell replacement. [Image: see text] [Image: see text] DISCLOSURES: All Authors: No reported Disclosures. |
format | Online Article Text |
id | pubmed-6808863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68088632019-10-28 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD Golob, Jonathan L DeMeules, Martha M Loeffelholz, Tillie Quinn, Z Z Dame, Michael K Silvestri, Sabrina Wu, Michael Schmidt, Tom Fiedler, Tina L Hoostal, Matthew Mielcarek, Marco Spence, Jason Pergam, Steven A Fredricks, David Open Forum Infect Dis Abstracts BACKGROUND: Steroid refractory acute graft- vs. -host-disease (GVHD) after hematopoietic cell transplantation (HCT) is highly morbid with limited treatment options. Murine studies show protection from GVHD with butyrate exposure but direct exposure of stem/progenitor cells to butyrate inhibits colonic stem cell proliferation. METHODS: Stool samples were collected weekly in a cohort of HCT recipients (n = 210) undergoing allogeneic transplant, and underwent 16S rRNA sequencing to determine the number and relative abundance of butyrogens. Dissociated primary human colonoid cell aggregates (200,000 per well) were plated onto collagen IV-coated transwells (0.4 µm pore size, 0.33 cm(2), PET) in stem cell medium for 24 hours. From 24 hours onwards, the basal-lateral chamber was switched to differentiation medium; the apical chamber was Hanks Buffered Salt Solution (HBSS), HBSS with 10 mM butyrate sodium salt early (24 hours onwards) or late (72hours onwards). Trans-epithelial electrical resistance was measured daily. RESULTS: Retrospective chart review identified 27 recipients who developed acute GVHD of the gut, stratified to be either steroid refractory GVHD (failed to respond to 2 mg/kg of methylprednisolone) or responsive. The presence of butyrogens in the gut microbiome after the onset of severe acute GHVD of the gut associated with increased risk of steroid refractory GVHD (Figure 1; P < 0.05). Direct exposure of human colonic stem/progenitor cells to butyrate inhibits the development of trans-epithelial electrical resistance; exposure after differentiation had no inhibition of barrier formation (Figure 2; P < 0.05 by T-test). CONCLUSION: Butyrogens may help prevent the development of acute GVHD of the gut, but once severe GVHD has developed may inhibit recovery due to the loss of crypt architecture exposing colonic stem cells to microbe-produced butyrate with impaired differentiation and cell replacement. [Image: see text] [Image: see text] DISCLOSURES: All Authors: No reported Disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6808863/ http://dx.doi.org/10.1093/ofid/ofz359.149 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Golob, Jonathan L DeMeules, Martha M Loeffelholz, Tillie Quinn, Z Z Dame, Michael K Silvestri, Sabrina Wu, Michael Schmidt, Tom Fiedler, Tina L Hoostal, Matthew Mielcarek, Marco Spence, Jason Pergam, Steven A Fredricks, David 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD |
title | 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD |
title_full | 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD |
title_fullStr | 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD |
title_full_unstemmed | 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD |
title_short | 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD |
title_sort | 2844. butyrogenic bacteria after acute graft vs. host disease associate with the development of steroid refractory gvhd |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808863/ http://dx.doi.org/10.1093/ofid/ofz359.149 |
work_keys_str_mv | AT golobjonathanl 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT demeulesmartham 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT loeffelholztillie 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT quinnzz 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT damemichaelk 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT silvestrisabrina 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT wumichael 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT schmidttom 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT fiedlertinal 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT hoostalmatthew 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT mielcarekmarco 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT spencejason 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT pergamstevena 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd AT fredricksdavid 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd |